Hospital Gene Therapy Aims to Free Patients from Chronic Pain

📆 10/28/2023 10:25 PM
📰 medical_xpress

⏱ Reading Time:
45 sec. here
2 min. at publisher
📊 Quality Score:
News: 21%
Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A new gene therapy treatment being developed at a hospital aims to provide long-term relief from chronic pain for patients. The therapy targets specific genes involved in pain signaling and aims to modify them to reduce pain sensitivity. Early trials have shown promising results, with patients experiencing significant pain reduction. If successful, this gene therapy could revolutionize the treatment of chronic pain and provide a much-needed alternative to opioids.

retrieved 28 October 2023 from https://medicalxpress.com/news/2023-10-hospital-gene-therapy-aims-free.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Adjunctive Tongxinluo therapy aids ST-segment elevation myocardial infarction outcomes: StudyIn patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy to guideline-directed treatment, is associated with significantly improved clinical outcomes, according to a study published in the Oct. 24/31 issue of the Journal of the American Medical Association.
Source: medical_xpress - 🏆 101. / 51 Read more »